Replies to post #140203 on Biotech Values

[DewDiligence]

Crucell/JNJ and Royal DSM terminate Percivia FoB collaboration inked in Sep 2010:

http://www.fiercebiotech.com/story/crucell-and-royal-dsm-pull-plug-biosimilar-jv/2012-04-18

Percivia will continue to exist as a JV, but only as a vehicle for promoting the PER.C6 business. (The 2010 PR announcing the expansion into FoB’s is at http://www.dsm.com/en_US/cworld/public/media/pages/press-releases/41_10_dsm_crucell_announce_expansion_percivia_per_c6_joint_venture.jsp .)

p.s. I don’t have to update the table in #msg-74411612 because I had never added an entry for Percivia in the table :- )

[DewDiligence]

Major FoB Collaborations

[Added entry for WPI-Bioton.]

 
                 Date   Targets  iHub References 
 Fujifilm-Kyowa  3/12   Humira   #msg-73800486 
 WPI-Bioton      2/12   insulin  #msg-74987123 
 WPI-AMGN       12/11   oncology #msg-70097496, #msg-70101928 
 BAX-MNTA       12/11   various  #msg-70212854, #msg-70258421 
 Samsung-BIIB   12/11   various  #msg-69629103 
 MRK-Hanwha      6/11   Enbrel   #msg-64164954, #msg-64193403  
 MYL-Biocon      6/09   various  #msg-39119393, #msg-72421544  
 TEVA-Lonza      1/09   various  #msg-34930012, #msg-34991518